For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $23.32 in the prior trading day, Corcept Therapeutics Inc (NASDAQ: CORT) closed at $23.88, up 2.40%. In other words, the price has increased by $2.40 from its previous closing price. On the day, 1.82 million shares were traded. CORT stock price reached its highest trading level at $24.61 during the session, while it also had its lowest trading level at $22.6.
Ratios:
Our goal is to gain a better understanding of CORT by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.71 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.48. For the most recent quarter (mrq), Quick Ratio is recorded 4.31 and its Current Ratio is at 4.39. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 04 ’24 when Lyon Joseph Douglas sold 5,443 shares for $26.00 per share. The transaction valued at 141,524 led to the insider holds 7,314 shares of the business.
Swisher Daniel N JR sold 2,200 shares of CORT for $55,660 on Apr 01 ’24. The Director now owns 0 shares after completing the transaction at $25.30 per share. On Apr 01 ’24, another insider, Lyon Joseph Douglas, who serves as the insider of the company, sold 500 shares for $26.01 each. As a result, the insider received 13,004 and left with 7,314 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORT now has a Market Capitalization of 2479627520 and an Enterprise Value of 2103925248. As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.19, and their Forward P/E ratio for the next fiscal year is 23.34. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.12 while its Price-to-Book (P/B) ratio in mrq is 4.87. Its current Enterprise Value per Revenue stands at 4.362 whereas that against EBITDA is 19.423.
Stock Price History:
Over the past 52 weeks, CORT has reached a high of $34.28, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is 0.38%, while the 200-Day Moving Average is calculated to be -10.15%.
Shares Statistics:
The stock has traded on average 1.11M shares per day over the past 3-months and 1493240 shares per day over the last 10 days, according to various share statistics. A total of 103.41M shares are outstanding, with a floating share count of 89.19M. Insiders hold about 13.84% of the company’s shares, while institutions hold 81.21% stake in the company. Shares short for CORT as of 1713139200 were 21122317 with a Short Ratio of 18.96, compared to 1710460800 on 20215345. Therefore, it implies a Short% of Shares Outstanding of 21122317 and a Short% of Float of 28.67.
